EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹584 Cr | ₹812 Cr | ₹1,377 Cr | ₹905 Cr | ₹868 Cr |
What is the latest Total Non-Current Liabilities ratio of EMCURE PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹584 Cr |
| Mar2025 | ₹812 Cr |
| Mar2024 | ₹1,377 Cr |
| Mar2023 | ₹905 Cr |
| Mar2022 | ₹868 Cr |
How is Total Non-Current Liabilities of EMCURE PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹584 Cr | -28.05 | |
| Mar2025 | ₹812 Cr | -41.04 | |
| Mar2024 | ₹1,377 Cr | 52.24 | |
| Mar2023 | ₹905 Cr | 4.16 | |
| Mar2022 | ₹868 Cr | - | |
Compare Total Non-Current Liabilities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹44,314.9 Cr | -0.1% | 30.9% | 68.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -0.1% |
30.9% |
68.1% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses